Tender for PBAC review, PBAC on biosimilar “a” flagging, Examine PBS change possible consequences, PBAC recommends melanoma therapy, and much more
Click here to download Pharmacy Daily for Tuesday 28th April 2015
PARTNER SITES
Other recent headlines
-
MDR’s results surpass expectations
Tuesday | Apr 23 2024MEDICATION management platform MedAdvisor Limited (MDR) showed strong financial performance for the quarter concluded on 31 Mar 2024, with operating revenue up 42% to $24.2 million from $17 million for the same period last year.
-
Call to restructure CSO
Tuesday | Apr 23 2024PHARMACIES in regional areas need a restructure of the 8CPA Community Service Obligation (CSO) to help fund them to support their workforce and deliver services, says the Remote and Isolated Pharmacist Association Australia (RIPAA).
-
Camden takes top spot
Tuesday | Apr 23 2024CAMDEN Day and Night Pharmacy has clinched the top prize in the Pharmacy category at the 2024 Australian Small Business Champion Awards recently.
to top